APA

Stakkestad J. A., Benevolenskaya L. I., Stepan J. J., Skag A., Nordby A., Oefjord E., Burdeska A., Jonkanski I. & Mahoney P. (20031208). Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women. : Annals of the rheumatic diseases.

Chicago

Stakkestad J A, Benevolenskaya L I, Stepan J J, Skag A, Nordby A, Oefjord E, Burdeska A, Jonkanski I and Mahoney P. 20031208. Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women. : Annals of the rheumatic diseases.

Harvard

Stakkestad J. A., Benevolenskaya L. I., Stepan J. J., Skag A., Nordby A., Oefjord E., Burdeska A., Jonkanski I. and Mahoney P. (20031208). Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women. : Annals of the rheumatic diseases.

MLA

Stakkestad J A, Benevolenskaya L I, Stepan J J, Skag A, Nordby A, Oefjord E, Burdeska A, Jonkanski I and Mahoney P. Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women. : Annals of the rheumatic diseases. 20031208.